Nimitz Health
Your guide to health policy in Washington, DC
States defended their anti-fraud efforts before Congress.
Senators examined vulnerabilities in healthcare, technology, and national security.
Experts outlined reforms aimed at improving transparency and competition.
The latest on appropriations, public health oversight, state implementation challenges, and HHS priorities.
Lawmakers debated innovation, competition, and biosimilar access as the Supreme Court weighed in.
Lawmakers examined foreign manufacturing, patient safety, and FDA oversight gaps.
From Medicaid work requirements to infectious disease preparedness, here's what you need to know.
The latest federal, state, and industry developments shaping healthcare policy in Washington and beyond.
MAHA Momentum, Maternal Health, and FDA Scrutiny Lead the Week
The key pressures fueling higher bills and premiums
Drug pricing, behavioral health, and oversight take center stage
Hospice scams, fake providers, and what’s driving it.
